Livzon Pharmaceutical Group Inc (SHE:000513) — Stock Price

CN¥30.73 CNY
▲ 0.16% today

Livzon Pharmaceutical Group Inc (SHE:000513) is currently trading at CN¥30.73 CNY, up 0.16% today. Over the past 52 weeks, shares have ranged between CN¥28.43 and CN¥42.41. This page tracks Livzon Pharmaceutical Group Inc's live share price on the SHE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Livzon Pharmaceutical Group Inc stock valuation.

Livzon Pharmaceutical Group Inc (000513) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Livzon Pharmaceutical Group Inc's daily closing share price and trading volume on the SHE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Livzon Pharmaceutical Group Inc Income Statement — Revenue, Profit & Earnings by Year

Livzon Pharmaceutical Group Inc's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue CN¥11.91 Billion CN¥11.81 Billion CN¥12.43 Billion CN¥12.63 Billion CN¥12.06 Billion
Cost of Revenue CN¥4.28 Billion CN¥4.25 Billion CN¥4.77 Billion CN¥4.58 Billion CN¥4.31 Billion
Gross Profit CN¥7.63 Billion CN¥7.56 Billion CN¥7.66 Billion CN¥8.05 Billion CN¥7.75 Billion
Research & Development CN¥842.84 Million CN¥1.03 Billion CN¥1.33 Billion CN¥1.43 Billion CN¥1.15 Billion
SG&A CN¥3.30 Billion CN¥613.06 Million CN¥654.27 Million CN¥656.86 Million CN¥664.18 Million
Total Operating Expenses CN¥5.01 Billion CN¥4.72 Billion CN¥5.24 Billion CN¥5.70 Billion CN¥5.49 Billion
Operating Income CN¥2.62 Billion CN¥2.84 Billion CN¥2.42 Billion CN¥2.35 Billion CN¥2.27 Billion
EBITDA CN¥3.18 Billion CN¥3.09 Billion CN¥2.74 Billion CN¥2.56 Billion CN¥2.34 Billion
EBIT CN¥2.62 Billion CN¥2.54 Billion CN¥1.92 Billion CN¥1.93 Billion CN¥1.92 Billion
Interest Expense CN¥61.74 Million CN¥93.01 Million CN¥106.89 Million CN¥103.06 Million CN¥87.87 Million
Income Before Tax CN¥2.86 Billion CN¥2.81 Billion CN¥2.38 Billion CN¥2.33 Billion CN¥2.25 Billion
Income Tax Expense CN¥451.01 Million CN¥501.66 Million CN¥485.07 Million CN¥374.97 Million CN¥293.59 Million
Net Income CN¥2.02 Billion CN¥2.06 Billion CN¥1.95 Billion CN¥1.91 Billion CN¥1.78 Billion

Livzon Pharmaceutical Group Inc Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Livzon Pharmaceutical Group Inc's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets CN¥23.99 Billion CN¥24.46 Billion CN¥25.04 Billion CN¥24.87 Billion CN¥22.37 Billion
Total Current Assets CN¥16.12 Billion CN¥16.42 Billion CN¥17.27 Billion CN¥16.99 Billion CN¥14.67 Billion
Cash & Equivalents — — — — —
Short-term Investments CN¥1.62 Billion CN¥89.36 Million CN¥81.79 Million CN¥108.09 Million CN¥182.77 Million
Net Receivables CN¥3.50 Billion CN¥3.28 Billion CN¥3.61 Billion CN¥4.08 Billion CN¥3.34 Billion
Inventory CN¥1.56 Billion CN¥2.00 Billion CN¥2.06 Billion CN¥2.05 Billion CN¥1.66 Billion
Property, Plant & Equipment — — — — CN¥4.24 Billion
Goodwill CN¥124.91 Million CN¥124.91 Million CN¥124.91 Million CN¥103.04 Million CN¥103.04 Million
Total Liabilities CN¥8.20 Billion CN¥9.55 Billion CN¥10.28 Billion CN¥9.93 Billion CN¥8.06 Billion
Total Current Liabilities CN¥7.22 Billion CN¥7.63 Billion CN¥8.09 Billion CN¥7.40 Billion CN¥6.93 Billion
Long-term Debt CN¥749.36 Million CN¥1.47 Billion CN¥1.61 Billion CN¥1.97 Billion CN¥636.78 Million
Net Debt CN¥-5.46 Billion CN¥-6.89 Billion CN¥-7.84 Billion CN¥-6.80 Billion CN¥-6.46 Billion
Total Stockholder Equity CN¥13.89 Billion CN¥13.86 Billion CN¥14.04 Billion CN¥13.88 Billion CN¥13.00 Billion
Retained Earnings CN¥12.74 Billion CN¥11.76 Billion CN¥10.91 Billion CN¥10.44 Billion CN¥9.72 Billion

Livzon Pharmaceutical Group Inc Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Livzon Pharmaceutical Group Inc generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow CN¥3.18 Billion CN¥2.98 Billion CN¥3.25 Billion CN¥2.77 Billion CN¥1.90 Billion
Capital Expenditures CN¥574.14 Million CN¥570.16 Million CN¥820.45 Million CN¥940.15 Million CN¥1.31 Billion
Free Cash Flow CN¥2.60 Billion CN¥2.41 Billion CN¥2.43 Billion CN¥1.83 Billion CN¥593.23 Million
Investing Cash Flow CN¥-3.77 Billion CN¥-660.33 Million CN¥-708.37 Million CN¥-1.23 Billion CN¥-1.88 Billion
Financing Cash Flow CN¥-2.69 Billion CN¥-2.49 Billion CN¥-1.66 Billion CN¥-720.36 Million CN¥-815.02 Million
Dividends Paid CN¥982.06 Million CN¥1.34 Billion CN¥1.49 Billion CN¥1.22 Billion CN¥1.17 Billion
Stock-Based Compensation — — CN¥76.73 Million CN¥47.32 Million CN¥32.73 Million
Depreciation CN¥553.34 Million CN¥575.14 Million CN¥840.32 Million CN¥652.32 Million CN¥445.27 Million
Change in Cash CN¥-1.52 Billion CN¥-158.55 Million CN¥903.72 Million CN¥947.33 Million CN¥-826.74 Million

Livzon Pharmaceutical Group Inc Earnings History — EPS Actual vs. Analyst Estimates

Track Livzon Pharmaceutical Group Inc's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 23, 2026 0.65 0.72 -9.72%
Mar 24, 2026 0.31 0.37 -16.22%
Oct 21, 2025 0.53 0.60 -11.67%
Aug 20, 2025 0.72 0.57 +26.32%
Apr 23, 2025 0.71 0.70 +1.43%
Mar 26, 2025 0.43 0.37 +16.22%
Oct 23, 2024 0.54 0.57 -5.26%
Aug 22, 2024 0.62 0.55 +12.73%